The store will not work correctly when cookies are disabled.
2-(1H-benzimidazol-1-yl)-N-[(hydroxy-(5-nitrofuran-2-yl)methyl)]-acetamide
ID: ALA454418
PubChem CID: 25110573
Max Phase: Preclinical
Molecular Formula: C14H12N4O5
Molecular Weight: 316.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Cn1cnc2ccccc21)NC(O)c1ccc([N+](=O)[O-])o1
Standard InChI: InChI=1S/C14H12N4O5/c19-12(7-17-8-15-9-3-1-2-4-10(9)17)16-14(20)11-5-6-13(23-11)18(21)22/h1-6,8,14,20H,7H2,(H,16,19)
Standard InChI Key: KFKIIAOVJGRNFB-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
5.5244 -26.1260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0445 -26.7694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8597 -26.6400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8174 -25.3571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6308 -25.2244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1579 -25.8669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9319 -25.5642 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8831 -24.7345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0790 -24.5246 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6266 -26.0091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3593 -25.6300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0540 -26.0749 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3973 -24.8058 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7867 -25.6957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4814 -26.1407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8247 -24.8716 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5332 -26.9615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3314 -27.1700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7764 -26.4752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2531 -25.8375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6038 -26.4236 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9736 -25.6861 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0575 -27.1126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10 11 1 0
11 12 1 0
2 3 1 0
11 13 2 0
3 6 2 0
12 14 1 0
1 2 2 0
14 15 1 0
5 4 2 0
14 16 1 0
15 17 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 15 1 0
4 1 1 0
7 10 1 0
5 6 1 0
21 22 2 0
21 23 1 0
19 21 1 0
M CHG 2 21 1 23 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 316.27 | Molecular Weight (Monoisotopic): 316.0808 | AlogP: 1.34 | #Rotatable Bonds: 5 |
Polar Surface Area: 123.43 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.55 | CX Basic pKa: 5.55 | CX LogP: 0.83 | CX LogD: 0.82 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.42 | Np Likeness Score: -1.63 |
References
1. Saczewski F, Stencel A, Bieńczak AM, Langowska KA, Michaelis M, Werel W, Hałasa R, Reszka P, Bednarski PJ.. (2008) Structure-activity relationships of novel heteroaryl-acrylonitriles as cytotoxic and antibacterial agents., 43 (9): [PMID:18187237] [10.1016/j.ejmech.2007.11.017] |